147 related articles for article (PubMed ID: 6103766)
41. Effect of human chorionic gonadotrophin (hCG)/follicle-stimulating hormone treatment versus hCG treatment alone on testicular descent: a double-blind placebo-controlled study.
Hoorweg-Nijman JJ; Havers HM; Delemarre-van de Waal HA
Eur J Endocrinol; 1994 Jan; 130(1):60-4. PubMed ID: 7907261
[TBL] [Abstract][Full Text] [Related]
42. Gonadal control of pulsatile secretion of luteinizing hormone and follicle-stimulating hormone in prepubertal boys evaluated by ultrasensitive time-resolved immunofluorometric assays.
Dunkel L; Alfthan H; Stenman UH; Perheentupa J
J Clin Endocrinol Metab; 1990 Jan; 70(1):107-14. PubMed ID: 2104623
[TBL] [Abstract][Full Text] [Related]
43. Hypothalamo-pituitary-gonadal axis in children with chronic renal failure.
Oertel PJ; Lichtwald K; Häfner S; Rauh W; Schönberg D; Schärer K
Kidney Int Suppl; 1983 Nov; 15():S34-9. PubMed ID: 6423876
[TBL] [Abstract][Full Text] [Related]
44. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
[TBL] [Abstract][Full Text] [Related]
45. Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy.
Happ J; Kollmann F; Krawehl C; Neubauer M; Krause U; Demisch K; Sandow J; Von Rechenberg W; Beyer J
Fertil Steril; 1978 May; 29(5):546-51. PubMed ID: 27391
[TBL] [Abstract][Full Text] [Related]
46. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.
Feuillan PP; Jones JV; Barnes KM; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 2000 Nov; 85(11):4036-8. PubMed ID: 11095429
[TBL] [Abstract][Full Text] [Related]
47. Plasma gonadotropin and testosterone values in infants with cryptorchidism.
Gendrel D; Roger M; Job JC
J Pediatr; 1980 Aug; 97(2):217-20. PubMed ID: 6105174
[TBL] [Abstract][Full Text] [Related]
48. LH-RH nasal spray treatment for cryptorchidism. A double-blind, placebo-controlled study.
De Muinck Keizer-Schrama SM; Hazebroek FW; Drop SL; Molenaar JC; Visser HK
Eur J Pediatr; 1987; 146 Suppl 2():S35-7. PubMed ID: 2891518
[TBL] [Abstract][Full Text] [Related]
49. [The significance and characteristics of the LHRH test in diagnosing precocious puberty development in girls: the stimulated LH/FSH quotient differentiates between central precocious puberty and premature thelarche].
Partsch CJ; Hümmelink R; Lorenzen F; Sippell WG
Monatsschr Kinderheilkd; 1989 May; 137(5):284-8. PubMed ID: 2525665
[TBL] [Abstract][Full Text] [Related]
50. Abnormal prolactin secretion in prepubertal boys with hypogonadotrophic hypogonadism--possible involvement in regulation of testicular steroidogenesis.
Dunkel L; Huhtaniemi I
Int J Androl; 1985 Oct; 8(5):385-92. PubMed ID: 2868996
[TBL] [Abstract][Full Text] [Related]
51. Intranasal LH-RH for cryptorchidism: response to initial treatment and to treatment after relapse.
Borkenstein M
Eur J Pediatr; 1987; 146 Suppl 2():S42-3. PubMed ID: 2891521
[TBL] [Abstract][Full Text] [Related]
52. Direct actions of the luteinizing hormone-releasing hormone agonist, deslorelin, on anterior pituitary contents of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), LH and FSH subunit messenger ribonucleic acid, and plasma concentrations of LH and FSH in castrated male cattle.
Aspden WJ; Rao A; Scott PT; Clarke IJ; Trigg TE; Walsh J; D'Occhio MJ
Biol Reprod; 1996 Aug; 55(2):386-92. PubMed ID: 8828844
[TBL] [Abstract][Full Text] [Related]
53. The antiprogestin RU486 dissociates LH and FSH secretion in male rats: evidence for direct action at the pituitary level.
Sánchez-Criado JE; Bellido C; Tébar M; Ruiz A; Gonzalez D
J Endocrinol; 1999 Feb; 160(2):197-203. PubMed ID: 9924188
[TBL] [Abstract][Full Text] [Related]
54. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
Lahlou N; Roger M; Chaussain JL; Feinstein MC; Sultan C; Toublanc JE; Schally AV; Scholler R
J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
[TBL] [Abstract][Full Text] [Related]
55. Plasma LH and FSH response to LRH and plasma testosterone levels in boys with irregular puberty.
Dickerman Z; Bar-Haim Y; Prager-Lewin R; Kaufman H; Laron Z
Acta Endocrinol (Copenh); 1977 Jul; 85(3):459-64. PubMed ID: 325981
[TBL] [Abstract][Full Text] [Related]
56. Serum inhibin levels before and after gonadotropin stimulation in cryptorchid boys under age 4 years.
Longui CA; Arnhold IJ; Mendonca BB; D'Osvaldo AF; Bloise W
J Pediatr Endocrinol Metab; 1998; 11(6):687-92. PubMed ID: 9829221
[TBL] [Abstract][Full Text] [Related]
57. Specific control of follicle stimulating hormone in the male: postulated site of action of inhibin.
Bramble FJ; Houghton AL; Eccles SS; Murray MA; Jacobs HS
Clin Endocrinol (Oxf); 1975 Jul; 4(4):443-9. PubMed ID: 238774
[TBL] [Abstract][Full Text] [Related]
58. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
[TBL] [Abstract][Full Text] [Related]
59. Clinical studies in an adult male patient with "isolated follicle stimulating hormone (FSH) deficiency".
Mozaffarian GA; Higley M; Paulsen CA
J Androl; 1983; 4(6):393-8. PubMed ID: 6140252
[TBL] [Abstract][Full Text] [Related]
60. Reduced inhibin and elevated gonadotropin levels in early pubertal boys with testicular defects.
Dunkel L; Siimes MA; Bremner WJ
Pediatr Res; 1993 May; 33(5):514-8. PubMed ID: 8511026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
